论文部分内容阅读
目的:鼻咽癌放疗联合多西他赛同期化疗的临床观察。方法:选取肇庆市第二人民医院2014年6月至2016年6月共30例鼻咽癌患者作为研究对象,以随机分配为原则,分为观察组和对照组各15例。观察组通过多西他赛同期化疗,对照组通过顺铂同期化疗,对比两组患者的临床疗效。结果:观察组远期疗效与对照组患者比较,差异无统计学意义(P>0.05);观察组患者不良反应情况与对照组比较,差异具有统计学意义(P<0.05)。结论:鼻咽癌放疗联合多西他赛同期化疗具有较好的临床效果,不良反应发生率及严重程度较低。
Objective: Nasopharyngeal carcinoma radiotherapy combined with docetaxel in the same period chemotherapy. Methods: A total of 30 patients with nasopharyngeal carcinoma from the Second People’s Hospital of Zhaoqing from June 2014 to June 2016 were selected as the research subjects. Randomly allocated as the principle, they were divided into observation group and control group, 15 cases each. The observation group through docetaxel simultaneous chemotherapy, the control group by cisplatin concurrent chemotherapy, compared the clinical efficacy of two groups of patients. Results: There was no significant difference in the long-term efficacy between the observation group and the control group (P> 0.05). The adverse reactions in the observation group were statistically significant compared with the control group (P <0.05). Conclusion: Radiotherapy combined with docetaxel nasopharyngeal carcinoma chemotherapy has good clinical efficacy, the incidence and severity of adverse reactions is low.